ES2747993T8 - Composiciones farmacéuticas de liberación prolongada de levetiracetam - Google Patents
Composiciones farmacéuticas de liberación prolongada de levetiracetamInfo
- Publication number
- ES2747993T8 ES2747993T8 ES16728462T ES16728462T ES2747993T8 ES 2747993 T8 ES2747993 T8 ES 2747993T8 ES 16728462 T ES16728462 T ES 16728462T ES 16728462 T ES16728462 T ES 16728462T ES 2747993 T8 ES2747993 T8 ES 2747993T8
- Authority
- ES
- Spain
- Prior art keywords
- levetiracetam
- extended
- pharmaceutical compositions
- release pharmaceutical
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562165812P | 2015-05-22 | 2015-05-22 | |
| PCT/US2016/033567 WO2016191288A1 (en) | 2015-05-22 | 2016-05-20 | Extended release pharmaceutical compositions of levetiracetam |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2747993T3 ES2747993T3 (es) | 2020-03-12 |
| ES2747993T8 true ES2747993T8 (es) | 2021-03-30 |
Family
ID=61223552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16728462T Active ES2747993T3 (es) | 2015-05-22 | 2016-05-20 | Composiciones farmacéuticas de liberación prolongada de levetiracetam |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3590506A1 (es) |
| DK (1) | DK3297611T3 (es) |
| ES (1) | ES2747993T3 (es) |
| MA (1) | MA50634A (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023192686A1 (en) * | 2022-04-01 | 2023-10-05 | Li shi jiang | Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1897959A1 (en) | 2002-11-22 | 2008-03-12 | The Johns Hopkins University | Target for therapy of cognitive impairment |
| EP2682481A3 (en) | 2005-08-03 | 2014-09-17 | The Johns-Hopkins University | Methods for characterizing and treating cognitive impairment in aging and disease |
| US20080014264A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
| CN107243007A (zh) * | 2008-10-16 | 2017-10-13 | 约翰斯.霍普金斯大学 | 改善认知功能的方法和组合物 |
| KR20120055313A (ko) * | 2010-11-23 | 2012-05-31 | 주식회사 바이오파마티스 | 레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법 |
| DE102011103270A1 (de) * | 2011-05-26 | 2012-11-29 | Stada Arzneimittel Ag | Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten |
| CA2904767C (en) * | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
-
2016
- 2016-05-20 DK DK16728462.9T patent/DK3297611T3/da active
- 2016-05-20 EP EP19175798.8A patent/EP3590506A1/en active Pending
- 2016-05-20 MA MA050634A patent/MA50634A/fr unknown
- 2016-05-20 EP EP16728462.9A patent/EP3297611B1/en active Active
- 2016-05-20 ES ES16728462T patent/ES2747993T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3590506A1 (en) | 2020-01-08 |
| ES2747993T3 (es) | 2020-03-12 |
| MA50634A (fr) | 2021-04-28 |
| EP3297611A1 (en) | 2018-03-28 |
| DK3297611T3 (da) | 2019-09-02 |
| EP3297611B1 (en) | 2019-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102281667B9 (ko) | 아트로핀 약학 조성물 (atropine pharmaceutical compositions) | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| MA44702A (fr) | Compositions de suspension à libération prolongée | |
| IL271657A (en) | medical preparation | |
| DK3253382T3 (da) | Farmaceutiske sammensætninger til kombinationsterapi | |
| DK3785733T3 (da) | Farmaceutisk sammensætning til behandling af autisme | |
| ES2972229T3 (es) | Composiciones farmacéuticas de apremilast | |
| IL287520A (en) | Levetiracetam extended-release pharmaceutical preparations | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| ES2972844T3 (es) | Preparación farmacéutica | |
| DK3278801T3 (da) | Farmaceutisk sammensætning indeholdende mirabegron | |
| MA49837A (fr) | Compositions pharmaceutiques | |
| MA47516A (fr) | Composition pharmaceutique | |
| GB201705303D0 (en) | Pharmaceutical compositions | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| GB201705305D0 (en) | Pharmaceutical compositions | |
| DK3672631T3 (da) | Farmaceutiske sammensætninger indeholdende anti-beta-amyloid-antistoffer | |
| GB201705306D0 (en) | Pharmaceutical compositions | |
| GB201705304D0 (en) | Pharmaceutical compositions | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| DK3288933T3 (da) | Oxindolforbindelser og farmaceutiske sammensætninger deraf | |
| DK3256138T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam | |
| DK3302483T3 (da) | Farmaceutiske sammensætninger og anvendelse deraf | |
| MA43126A (fr) | Compositions pharmaceutiques de fumarate de diméthyle | |
| ES2747993T8 (es) | Composiciones farmacéuticas de liberación prolongada de levetiracetam |